High levels of CEACAM5 expression are found in human patients in 80 - 90% of all colorectal cancers, in up to 50% of all breast and lung cancers and in about 15% of gastrointestinal and pancreatic carcinomas as well as in many other epithelial cancers [19]. This evidence concerns the gene CEACAM5 and colorectal cancer.